To evaluate if 0.04% MMC application at the ostium enhances the outcome of non-endoscopic endonasal dacryocystorhinostomy (NEED) in individuals with primary acquired nasolacrimal duct obstruction (PANDO)
This single modification changes the stability profile, the absorption characteristics, and the practical utility of the peptide in ways that matter enormously for researchers designing effective dosing protocols
Some individuals will clear faster, others slower
It proves its purity instead of just claiming it
Have you heard great things about B12 shots
When released (e.g., with vesicle depletion by reserpine or amphetamine) [69,70,152] it can substitute disturbed dopamine (i.e., shortage (reserpine) [69] or excess (amphetamine) [70]) as competing successfully for sites at dopamine receptors (i.e., counteracting the adverse effects of both dopamine agonists [70,152,153] and dopamine antagonists [68,70,152])